On September 25, 2018 SCYNEXIS, Inc. (NASDAQ:SCYX), a biotechnology company delivering innovative therapies for difficult-to-treat and often life-threatening infections, reported that the Company will present at the following upcoming investor conferences (Press release, Scynexis, SEP 25, 2018, View Source [SID1234529571]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The Ladenburg Thalmann 2018 Healthcare Conference at the Sofitel New York on Tuesday, October 2, 2018 at 10:30 a.m. ET.
Cantor Fitzgerald’s Global Healthcare Conference at InterContinental New York Barclay on Wednesday, October 3, 2018 at 2:15 p.m. ET.
Live webcasts of the presentations will be available on the Investors section of the Company’s website: www.scynexis.com. A replay of each presentation will be available approximately two hours after the event and will be available for two weeks following each presentation.